Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose chemotherapy with mitoxantrone + melphalan and autologous stem cell rescue in metastatic breast cancer patients: a study of feasibility and tolerability.
Martino M, Morabito F, Console G, Irrera G, Pucci G, Penna G, Dattola A, Callea I, Pontari A, Condemi A, Messina G, Nardi M, Cicero G, Molica S, Palazzo S, Iacopino P. Martino M, et al. Among authors: dattola a. Tumori. 2003 Sep-Oct;89(5):492-6. doi: 10.1177/030089160308900506. Tumori. 2003. PMID: 14870770 Clinical Trial.
The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation.
Fedele R, Martino M, Garreffa C, Messina G, Console G, Princi D, Dattola A, Moscato T, Massara E, Spiniello E, Irrera G, Iacopino P. Fedele R, et al. Among authors: dattola a. Blood Transfus. 2012 Apr;10(2):174-80. doi: 10.2450/2012.0034-11. Epub 2012 Jan 24. Blood Transfus. 2012. PMID: 22337266 Free PMC article.
Tildrakizumab and Quality of Life: Deep Dive into the Impact of Psoriasis and Treatment on Different Domains-Should Psychosocial Life Impairment Be Considered a Comorbidity?
Licata G, Di Brizzi EV, Castelli F, Giuffrida G, Stroppiana E, Dattola A, Richetta AG, De Col E, Peila R, Siliquini N, Solaroli C, Zanetta R, Cerulli E, Galdo G, Giordano D, Faure E, Papaianni V, Pertusi G, Uzzauto MT, Loconsole F, Zichichi L. Licata G, et al. Among authors: dattola a. J Clin Med. 2025 Jan 2;14(1):223. doi: 10.3390/jcm14010223. J Clin Med. 2025. PMID: 39797306 Free PMC article.
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.
Bernardini N, Dattola A, Rossi R, Pagnanelli G, Amerio P, Atzori L, Mugheddu C, Lora V, Giordano D, Guacci LF, Persechino S, Richetta AG, Skroza N, Potenza C. Bernardini N, et al. Among authors: dattola a. J Pers Med. 2024 Dec 22;14(12):1169. doi: 10.3390/jpm14121169. J Pers Med. 2024. PMID: 39728081 Free PMC article.
Diagnosing psoriatic arthritis in the early phase: what factors should dermatologists consider for an appropriate referral of patients with psoriasis to rheumatologists.
Galluzzo M, Scrivo R, Dattola A, D'Antonio A, Ortolan A, Giordano D, D'Agostino M, Picchianti Diamanti A. Galluzzo M, et al. Among authors: dattola a. Ital J Dermatol Venerol. 2024 Nov 4. doi: 10.23736/S2784-8671.24.07926-X. Online ahead of print. Ital J Dermatol Venerol. 2024. PMID: 39495494 No abstract available.
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study.
Dattola A, Bernardini N, Svara F, Balato A, Caldarola G, D'Amico D, De Simone C, Di Brizzi EV, Esposito M, Giofrè C, Giordano D, Guarneri C, Loconsole F, Lora V, Moretta G, Orsini D, Persechino S, Potenza C, Ragonesi S, Pellacani G, Peris K, Fargnoli MC, Richetta AG. Dattola A, et al. J Dermatolog Treat. 2024 Dec;35(1):2420825. doi: 10.1080/09546634.2024.2420825. Epub 2024 Oct 27. J Dermatolog Treat. 2024. PMID: 39462515 Free article.
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.
Campione E, Artosi F, Shumak RG, Giunta A, Argenziano G, Assorgi C, Balato A, Bernardini N, Brunasso AMG, Burlando M, Caldarola G, Campanati A, Carugno A, Castelli F, Conti A, Costanzo A, Cuccia A, Dapavo P, Dattola A, De Simone C, Di Lernia V, Dini V, Donini M, Errichetti E, Esposito M, Fargnoli MC, Foti A, Fiorella C, Gargiulo L, Gisondi P, Guarneri C, Legori A, Lembo S, Loconsole F, Malagoli P, Marzano AV, Mercuri SR, Megna M, Micali G, Mortato E, Musumeci ML, Narcisi A, Offidani AM, Orsini D, Paolino G, Pellacani G, Peris K, Potenza C, Prignano F, Quaglino P, Ribero S, Richetta AG, Romanelli M, Rossi A, Strippoli D, Trovato E, Venturini M, Bianchi L. Campione E, et al. Among authors: dattola a. Pharmaceuticals (Basel). 2024 Oct 16;17(10):1378. doi: 10.3390/ph17101378. Pharmaceuticals (Basel). 2024. PMID: 39459016 Free PMC article.
130 results